RxDoctor Payments Data

Kuldeep Singh, MD

Psychiatry · Munster, INNPI 1265674162

Payments from drug & device makers

$730in general payments, 2019–2025

Across 47 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$481
  • Otsuka America Pharmaceutical, Inc.$75
  • Lundbeck LLC$52
  • Teva Pharmaceuticals USA, Inc.$35
  • E.r. Squibb & Sons, L.L.C.$27
  • Johnson & Johnson$23
  • plus $36 from 2 others

What the payments were for

  • Food & beverage$67292%
  • Education$578%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$730 in reported general payments places this provider in the 60th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Medicare billing

Part B allowed, 2024
$34,111
Medicare patients
104
Services billed
398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$89,077
VraylarCariprazine Hcl49$67,714
Abilify MaintenaAripiprazole18$52,179
Risperdal ConstaRisperidone Microspheres14$26,669
Invega SustennaPaliperidone Palmitate14$25,645
TrintellixVortioxetine Hydrobromide18$11,306
Lurasidone Hcl11$6,274
Aripiprazole64$5,994
Quetiapine Fumarate187$2,764
Clomipramine Hcl26$2,610
Bupropion XlBupropion Hcl131$2,477
Buspirone Hcl94$1,881
Fluphenazine Hcl18$1,878
Trazodone Hcl135$1,753
Duloxetine Hcl106$1,723

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$481$67,71449 claims
Johnson & JohnsonRisperdal Consta, Invega Sustenna$23$52,31428 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$75$52,17918 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$16$11,30618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →